![Richard Hoyt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Hoyt
Chairman at
ZYUS LIFE SCIENCES CORPORATION
Net worth: 12 360 $ as of 2026-07-30
Profile
Mr. Richard Hoyt is a Chairman at ZYUS Life Sciences Corp., a Vice President-Business Development at Xeris Biopharma Holdings, Inc., a Chairman at ZYUS Life Sciences, Inc. and a Managing Partner at Ozark Transaction Advisors LLC.
Mr. Hoyt was previously employed as an Independent Director by CanniMed Therapeutics, Inc., a Vice President-Business Development & Licensing by Mallinckrodt Plc, and a Vice President-Business Development by Xeris Pharmaceuticals, Inc. He also served on the board at Biotechnology Research & Development Corp.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-11-25 | 309,002 ( 0.38% ) | 12 360 $ | 2026-07-30 |
Richard Hoyt active positions
| Companies | Position | Start |
|---|---|---|
| ZYUS LIFE SCIENCES CORPORATION | Chairman | 2020-08-31 |
| XERIS BIOPHARMA HOLDINGS, INC. | Corporate Officer/Principal | 2019-10-31 |
ZYUS Life Sciences, Inc.
 ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical manufacturing company | Chairman | - |
Ozark Transaction Advisors LLC | Corporate Officer/Principal | - |
Former positions of Richard Hoyt
| Companies | Position | End |
|---|---|---|
| MALLINCKRODT PLC | Corporate Officer/Principal | 2018-08-31 |
| CANNIMED THERAPEUTICS INC | Director/Board Member | 2018-03-14 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Corporate Officer/Principal | - |
Biotechnology Research & Development Corp.
 Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Provides research on animal and plant healthcare, material sciences and biotechnology | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
46
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Biotechnology Research & Development Corp.
Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Provides research on animal and plant healthcare, material sciences and biotechnology | Commercial Services |
CanniMed Therapeutics, Inc.
 CanniMed Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in production of pharmaceutical grade cannabis products | Health Technology |
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical manufacturing company | Health Technology |
Xeris Biopharma Holdings, Inc.
 Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
ZYUS Life Sciences Corp.
 ZYUS Life Sciences Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes cannabinoid-based pharmaceutical drug product candidates and therapeutics | Health Technology |
Ozark Transaction Advisors LLC |
- Stock Market
- Insiders
- Richard Hoyt
